Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor - PubMed (original) (raw)
. 1995 Oct 15;165(2):183-92.
doi: 10.1006/cimm.1995.1204.
Affiliations
- PMID: 7553882
- DOI: 10.1006/cimm.1995.1204
Free article
Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor
A J McAdam et al. Cell Immunol. 1995.
Free article
Abstract
We have investigated the role of cytokines (IL-2, IL-3, IL-4, IL-6, IFN-gamma, and GM-CSF) in the generation of primary cytotoxic T lymphocytes (CTL), within a single tumor system. The murine carcinoma line 1 was transfected with expression vectors with cDNA for these cytokines. Line 1 expresses low levels of class I MHC molecules, but can be induced with dimethyl sulfoxide or IFN-gamma to express high levels of class I. Class I low line 1 cells are not susceptible to CTL lysis, while class I high line 1 are lysed by CTL, which allows us to assay for CTL activity. To isolate primary CTL, tumor-infiltrating lymphocytes were isolated from cytokine-expressing or control tumors, growing in vivo. Most cytokines stimulated nonspecific killers, but IL-2 and IL-3 stimulated primary CTL. While IFN-gamma alone did not generate primary CTL, coexpression of IFN-gamma with IL-2 resulted in CTL generation. This is the first comparison of the effects of a series of cytokines on primary CTL development, and has important implications for vaccine development and immunotherapy.
Similar articles
- The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H. Ojima T, et al. Int J Oncol. 2006 Apr;28(4):947-53. Int J Oncol. 2006. PMID: 16525645 - Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A. Tso CL, et al. Cancer Res. 2001 Nov 1;61(21):7925-33. Cancer Res. 2001. PMID: 11691814 - Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M. Yamaguchi T, et al. Immunol Lett. 2008 Jun 15;118(1):88-95. doi: 10.1016/j.imlet.2008.03.005. Epub 2008 Apr 10. Immunol Lett. 2008. PMID: 18440651 - Experimental and clinical studies of cytokine gene-modified tumor cells.
Tepper RI, Mulé JJ. Tepper RI, et al. Hum Gene Ther. 1994 Feb;5(2):153-64. doi: 10.1089/hum.1994.5.2-153. Hum Gene Ther. 1994. PMID: 8186297 Review. - Tumour necrosis factor and associated cytokines in the host's response to malaria.
Richards AL. Richards AL. Int J Parasitol. 1997 Oct;27(10):1251-63. doi: 10.1016/s0020-7519(97)00122-7. Int J Parasitol. 1997. PMID: 9394195 Review.
Cited by
- Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases.
Puskas J, Skrombolas D, Sedlacek A, Lord E, Sullivan M, Frelinger J. Puskas J, et al. Immunology. 2011 Jun;133(2):206-20. doi: 10.1111/j.1365-2567.2011.03428.x. Epub 2011 Mar 23. Immunology. 2011. PMID: 21426339 Free PMC article. - Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy.
Wei C, Willis RA, Tilton BR, Looney RJ, Lord EM, Barth RK, Frelinger JG. Wei C, et al. Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6369-74. doi: 10.1073/pnas.94.12.6369. Proc Natl Acad Sci U S A. 1997. PMID: 9177224 Free PMC article. - IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms.
Sorensen EW, Gerber SA, Frelinger JG, Lord EM. Sorensen EW, et al. J Immunol. 2010 Feb 15;184(4):1858-66. doi: 10.4049/jimmunol.0903210. Epub 2010 Jan 8. J Immunol. 2010. PMID: 20061409 Free PMC article. - Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes.
Connolly KA, Belt BA, Figueroa NM, Murthy A, Patel A, Kim M, Lord EM, Linehan DC, Gerber SA. Connolly KA, et al. Oncotarget. 2016 Dec 27;7(52):86522-86535. doi: 10.18632/oncotarget.13287. Oncotarget. 2016. PMID: 27852031 Free PMC article. - Alteration of tumour response to radiation by interleukin-2 gene transfer.
Lee J, Moran JP, Fenton BM, Koch CJ, Frelinger JG, Keng PC, Lord EM. Lee J, et al. Br J Cancer. 2000 Feb;82(4):937-44. doi: 10.1054/bjoc.1999.1022. Br J Cancer. 2000. PMID: 10732769 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials